Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: UK vaccine center to help fight epidemics, global map of HIV reveals vaccine challenges, and researchers create antibodies to test and treat Zika

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

Research experts stress why investing in R&D works for the US and the world

With the ever-present specter of federal budget reductions that could impact global health and development programs, the GHTC’s event on Friday to launch our new report couldn’t have come at a better time.

GHTC
Read More
PATH/Will Boase
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New report confirms that US investments in global health research are paying off

Did you know that Americans spend more money on ice cream in three weeks than the US Government spends on global health research and development (R&D) in a year? And despite this relatively modest investment in the creation of new global health tools, the United States is the worldwide leader in R&D for neglected diseases.

GHTC
Read More
PATH/Aaron Joel Santos
What could you prove with $100,000?

Michel Zaffran is the coordinator for the Expanded Programme on Immunization at the World Health Organization (WHO). He is also the director of Project Optimize at PATH. In this guest post, Zaffran writes about how the Bill & Melinda Gates Foundation is seeking new ideas for immunization systems and vaccine product characteristics.

PATH
Read More
Investment in Malaria R&D Required to Sustain Gains and Save Lives

In this guest post, Mandy Goldberg from Research!America writes about an event today in Washington, DC, that focuses on research and development (R&D) for new malaria tools. The event is sponsored by Research!America, the Global Health Technologies Coalition (GHTC), and several other partners.

Research!America
Read More
Expanding the pneumonia fight: New vaccines for the world’s most vulnerable children

Mark Alderson, PhD, is the director of the pneumococcal vaccine project at PATH, a nonprofit international organization based in Seattle, Washington, specializing in global health. In this guest post, he writes about PATH’s efforts to develop new vaccines to fight pneumonia among children.

PATH
Read More
Can a mutant be a medical breakthrough?

The leading bacterial causes of diarrhea are enterotoxigenic Escherichia coli and Shigella, and vaccines against these pathogens could save the lives of up to a half-million children each year.

PATH
Read More
PATH/Doune Porter
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New York global health community comes together to discuss innovative partnerships in R&D

Research!America, a GHTC member, recently hosted an event on global health research and development (R&D) in New York. In this guest post, Mandy Goldberg, MPH, shares highlights from the event.

Research!America
Read More
New project launched in Africa to improve regulatory pathways and deliver better health products

Developing new medical products is a global enterprise, with research and development (R&D) activities spanning national borders and products being introduced in many countries at the same time.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
New report stresses strengthened regulatory systems abroad

The Institute of Medicine (IOM) yesterday released a new report that stresses the importance of bolstering regulatory systems abroad in order to improve the safety and quality of medical products circulating around the globe. According to the report, many low- and middle-income countries do not have sufficient regulatory capacity, which limits their ability to oversee medical products such as drugs and vaccines.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we're reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
What’s ahead on the Hill

In this feature on Breakthroughs, we provide an update on what’s currently happening with global health in Congress and an outlook for future legislative activity.

GHTC
Read More
The US Government and research and development for neglected tropical diseases: Most neglected patients still falling through the cracks

One billion people. That’s roughly how many people live in North America and Europe combined. And that’s also roughly how many people have at least one neglected tropical disease (NTD).

Read More
Recognizing World TB Day and the need for new health tools

As people across the globe celebrate World TB Day this week, several groups are highlighting the fact that the current tools to prevent, test, and treat tuberculosis (TB) are greatly outdated. The world has been “beyond antiquated in our approach” to developing new TB tools.

GHTC
Read More
PATH/Richard Franco
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
The beginning of the end

Phil Carroll, senior policy communications associate at PATH, writes about Marc LaForce, recently retired director of the Meningitis Vaccine Project. This post is part of an ongoing effort on Breakthroughs to highlight leaders and heroes in global health research and development (R&D).

PATH
Read More
USAID’s Shah continues leadership in science and innovation

Late last week, USAID Administrator Rajiv Shah released his second annual letter, outlining major issues and initiatives that have shaped the agency since its inception 50 years ago.

GHTC
Read More